TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8198892

Group type: EXPERIMENTAL
Intervention: Magnarail system (primary system)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Omniflex system (primary system)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall success rate
Number of subjects: 50
Study: 3145958

Group type: EXPERIMENTAL
Intervention: Lidocaine with adrenaline 1:80,000
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (Lidocaine without adrenaline)
Number of subjects: 5
Study: 28905123

Group type: EXPERIMENTAL
Intervention: Oscillating-rotating toothbrush with instruction (OR-I)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sonic-active toothbrush with instruction (SA-I)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Manual toothbrush with instruction (MTB-I)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sonic-active toothbrush without instruction (SA-NI)
Number of subjects: 150

Group type: COMPARATOR
Intervention: All toothbrush systems
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All toothbrush systems with instruction
Number of subjects: 150
Study: 27389186

Group type: EXPERIMENTAL
Intervention: Bullying and FKBP5 haplotype interaction
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Social stress appraisal (being alone due to social rejection)
Number of subjects: 206
Study: 25548107

Group type: EXPERIMENTAL
Intervention: Δ(9)‐tetrahydrocannabinol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 22753906

Group type: EXPERIMENTAL
Intervention: Patient-directed computerized decision aid (DA) with usual care
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual care alone (control)
Number of subjects: 74
Study: 20446632

Group type: EXPERIMENTAL
Intervention: Literature review and audit
Number of subjects: 0
Study: 18724149

Group type: EXPERIMENTAL
Intervention: 2-site phacotrabeculectomy
Number of subjects: 113

Group type: COMPARATOR
Intervention: 1-site phacotrabeculectomy
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both groups (1-site and 2-site)
Number of subjects: 113
Study: 16180528

Group type: EXPERIMENTAL
Intervention: Psychodynamic short-term psychotherapy (PSTP), 25 sessions
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Psychodynamic short-term psychotherapy (PSTP)
Number of subjects: 26
Study: 12824459

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg per day)
Number of subjects: 18882

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18882

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 18882
Study: 10913814

Group type: EXPERIMENTAL
Intervention: Ramipril (1.25 mg/day)
Number of subjects: 4937

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4937
Study: 8886348

Group type: EXPERIMENTAL
Intervention: Weekly iron supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Daily iron supplementation
Number of subjects: 0
Study: 1905836

Group type: EXPERIMENTAL
Intervention: Immune serum globulin (ISG) 2 ml i.m. at premedication and 2 ml i.m. on postoperative day 3
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (no gammaglobulin or placebo)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Immune serum globulin (ISG)
Number of subjects: 196
Study: 6351889

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (200 micrograms)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Inhaled reproterol (1 mg)
Number of subjects: 6
Study: 31752559

Group type: EXPERIMENTAL
Intervention: Inertial sensors used by Rater A
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Inertial sensors used by Rater B
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Inertial sensors (inter-rater reliability)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Inertial sensors (agreement measures)
Number of subjects: 20
Study: 29407289

Group type: EXPERIMENTAL
Intervention: I-SOCIAL intervention combining individual and group sessions to address social challenges
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 26906110

Group type: EXPERIMENTAL
Intervention: high-resolution black-blood MRI (hr-bb-cMRI)
Number of subjects: 43
Study: 1593145

Group type: EXPERIMENTAL
Intervention: Bupivacaine hydrochloride (one ml) and buprenorphine 300 micrograms in combination (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine hydrochloride (one ml) (Group A)
Number of subjects: 60
Study: 22723614

Group type: EXPERIMENTAL
Intervention: Multi-modal intervention (dietary counselling, controlled exercise, psychosocial support)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (CGr)
Number of subjects: 70
Study: 20350428

Group type: EXPERIMENTAL
Intervention: Probiotics treatment group (Clostridium butyricum powder, 250 mg, twice daily up to discharge)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Probiotics treatment group
Number of subjects: 70
Study: 18564698

Group type: EXPERIMENTAL
Intervention: Clofibate (100 mg/kg single oral dose)
Number of subjects: 40
Study: 16078334

Group type: EXPERIMENTAL
Intervention: Teriparatide 40 microg
Number of subjects: 146

Group type: COMPARATOR
Intervention: Alendronate 10 mg
Number of subjects: 146
Study: 12425125

Group type: EXPERIMENTAL
Intervention: Lidocaine, 1.5 mg/kg
Number of subjects: 74

Group type: COMPARATOR
Intervention: Rocuronium, 0.03 mg/kg
Number of subjects: 74
Study: 10325273

Group type: EXPERIMENTAL
Intervention: 3D endometrial ultrasound measurements (endometrial thickness and volume) on the day of oocyte retrieval
Number of subjects: 47
Study: 8611046

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 1049
Study: 2011700

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole once daily for 2 weeks
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole once daily for 4 weeks
Number of subjects: 450

Group type: COMPARATOR
Intervention: 300 mg ranitidine once daily for 2 weeks
Number of subjects: 450

Group type: COMPARATOR
Intervention: 300 mg ranitidine once daily for 4 weeks
Number of subjects: 450
Study: 6399407

Group type: EXPERIMENTAL
Intervention: Tinidazole (2-gram single dose)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 30632104

Group type: EXPERIMENTAL
Intervention: Activated standardized patients (SPs)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standardized patients (SPs)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Oncologists
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Primary care physicians (PCPs)
Number of subjects: 96
Study: 30081103

Group type: EXPERIMENTAL
Intervention: Real air purifier
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham air purifier
Number of subjects: 36
Study: 26753986

Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: GMT plus metacognitive training (GMT + Meta)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined GMT groups
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 24563385

Group type: EXPERIMENTAL
Intervention: Second DBS lead ON (double stimulation)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Vim DBS alone
Number of subjects: 5

Group type: COMPARATOR
Intervention: Second lead ON (Vim OFF)
Number of subjects: 5
Study: 23061078

Group type: EXPERIMENTAL
Intervention: Computer EBUS‐TBNA simulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Wet lab simulation
Number of subjects: 12
Study: 19825916

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES) 130/0.4
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 4% succinylated gelatin (GEL)
Number of subjects: 36

Group type: COMPARATOR
Intervention: lactated Ringer's (RL) solution
Number of subjects: 36
Study: 21305543

Group type: EXPERIMENTAL
Intervention: Moderate level of transference interpretations
Number of subjects: 0

Group type: COMPARATOR
Intervention: No transference interpretation
Number of subjects: 0
Study: 16040619

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 2599

Group type: COMPARATOR
Intervention: Metoprolol tartrate
Number of subjects: 2599

Group type: EXPERIMENTAL
Intervention: Beta-blocker dose
Number of subjects: 2599

Group type: EXPERIMENTAL
Intervention: Baseline HR and SBP
Number of subjects: 2599

Group type: EXPERIMENTAL
Intervention: HR above median and SBP below median at 4 months
Number of subjects: 2599
Study: 12898821

Group type: EXPERIMENTAL
Intervention: Abdominal aortography with selective angiography
Number of subjects: 35
Study: 9685764

Group type: EXPERIMENTAL
Intervention: Dental hygienist-delivered intervention for smokeless tobacco users
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (cigarette smokers)
Number of subjects: 75
Study: 7977730

Group type: EXPERIMENTAL
Intervention: Long-chain triglycerides (LCT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Mixture of long- and medium-chain triglycerides (MCT/LCT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: LCT or MCT/LCT at 70% of nonprotein caloric intake
Number of subjects: 16
Study: 2543094

Group type: EXPERIMENTAL
Intervention: gastrocepin (20 patients)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: dalargin (20 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (20 patients)
Number of subjects: 40
Study: 28863298

Group type: EXPERIMENTAL
Intervention: Assertive case management
Number of subjects: 914

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 914
Study: 28391116

Group type: EXPERIMENTAL
Intervention: Affective working memory training (aWMT) for 20 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo training (feature match task) for 20 days
Number of subjects: 30
Study: 26212489

Group type: EXPERIMENTAL
Intervention: E4/DRSP (5 mg or 10 mg E4/3 mg DRSP)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: E4/LNG (5 mg, 10 mg or 20 mg E4/150 μg LNG)
Number of subjects: 109

Group type: COMPARATOR
Intervention: EE/DRSP (20 μg EE/3 mg DRSP)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: E4/DRSP and E4/LNG
Number of subjects: 109
Study: 23435022

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 76
Study: 19940484

Group type: EXPERIMENTAL
Intervention: Gum chewing
Number of subjects: 150

Group type: COMPARATOR
Intervention: Non-gum-chewing (Control)
Number of subjects: 150
Study: 17645506

Group type: EXPERIMENTAL
Intervention: Epoetin 150 IU/kg three times weekly
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Epoetin
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control
Number of subjects: 74
Study: 16832680

Group type: EXPERIMENTAL
Intervention: Iloprost 1 ng/kg/min
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Iloprost 2 ng/kg/min
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 12803265

Group type: EXPERIMENTAL
Intervention: Group Def-3 (cuff deflation every 30 min for 3 hours)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group Def-4 (cuff deflation every 30 min for 4 hours)
Number of subjects: 20
Study: 11310081

Group type: EXPERIMENTAL
Intervention: Music therapy during the examination
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual procedural care (Control)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 64
Study: 8707479

Group type: EXPERIMENTAL
Intervention: Extracerebral applications of picotesla (pT) range electromagnetic fields (EMFs)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo EMF treatment
Number of subjects: 3
Study: 1731461

Group type: EXPERIMENTAL
Intervention: Sematilide (0.15 to 1.5 mg/kg over 15 minutes)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sematilide (high concentrations greater than or equal to 2 micrograms/ml)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sematilide (plasma concentrations greater than or equal to 0.8 micrograms/ml)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sematilide
Number of subjects: 14
Study: 6691639

Group type: EXPERIMENTAL
Intervention: Computer reminders generated by 1490 rules
Number of subjects: 12467

Group type: COMPARATOR
Intervention: Control group (no reminders)
Number of subjects: 12467

Group type: EXPERIMENTAL
Intervention: Study group intentions to use a given action
Number of subjects: 12467

Group type: COMPARATOR
Intervention: Control group intentions
Number of subjects: 12467
Study: 31553108

Group type: EXPERIMENTAL
Intervention: Recontact letter emphasizing personal medical management implications
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Recontact letter emphasizing implications for family members
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Recontact letter emphasizing both personal and family implications
Number of subjects: 586

Group type: COMPARATOR
Intervention: Control letter
Number of subjects: 586
Study: 30357570

Group type: EXPERIMENTAL
Intervention: Real-world studies
Number of subjects: 0
Study: 27015381

Group type: EXPERIMENTAL
Intervention: Trunk muscle stabilization exercise program (CO‐CUIDATE), conducted for 8 weeks, three times per week
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual-care group
Number of subjects: 46
Study: 24552894

Group type: EXPERIMENTAL
Intervention: Nerve-sparing laparoscopic radical hysterectomy (NS-LRH)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional laparoscopic radical hysterectomy (LRH)
Number of subjects: 96
Study: 22644797

Group type: EXPERIMENTAL
Intervention: 5-mg axitinib Form IV FCIR tablets with food
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 5-mg axitinib Form XLI FCIR tablets with high-fat, high-calorie meal
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 5-mg axitinib Form XLI FCIR tablets with moderate-fat, standard-calorie meal
Number of subjects: 48

Group type: COMPARATOR
Intervention: 5-mg axitinib Form IV FCIR tablets
Number of subjects: 48

Group type: COMPARATOR
Intervention: 5-mg axitinib Form XLI FCIR tablets
Number of subjects: 48
Study: 20196093

Group type: EXPERIMENTAL
Intervention: Recruitment strategies including relationship-building, raffles, and screening survey administration
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Retention strategies including cash incentives, flexible scheduling, multiple reminders, chapter incentives, and use of chapter members as study personnel
Number of subjects: 452
Study: 18848109

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 60
Study: 15747447

Group type: EXPERIMENTAL
Intervention: Intravenous fludarabine
Number of subjects: 1447

Group type: COMPARATOR
Intervention: Fludarabine (CAP protocol or CHOP protocol)
Number of subjects: 1447
Study: 11961622

Group type: EXPERIMENTAL
Intervention: MIST‐VR training
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no MIST‐VR training)
Number of subjects: 29
Study: 9856715

Group type: EXPERIMENTAL
Intervention: 1.2% isoflurane in oxygen and nitrogen
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2.0% isoflurane
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1.7% sevoflurane
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2.8% sevoflurane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 8548235

Group type: EXPERIMENTAL
Intervention: Preoperative total parenteral nutrition (TPN)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Enteral feeding (Control)
Number of subjects: 203
Study: 2794292

Group type: EXPERIMENTAL
Intervention: Strict elimination diet of offending foods followed by double-blind, placebo-controlled food challenges.
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Double-blind, placebo-controlled food challenges after 1 year or more of avoidance.
Number of subjects: 23
Study: 401604

Group type: EXPERIMENTAL
Intervention: Meglumine iodamide
Number of subjects: 78

Group type: COMPARATOR
Intervention: Renografin-60
Number of subjects: 78
Study: 28452242

Group type: EXPERIMENTAL
Intervention: Homecare Aide Workforce Initiative (HAWI) graduates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-HAWI new hires
Number of subjects: 0
Study: 28924473

Group type: EXPERIMENTAL
Intervention: Alcohol-only formulation (product A) applied for 90 s
Number of subjects: 25

Group type: COMPARATOR
Intervention: Chlorhexidine-alcohol combination (product B) applied for 180 s
Number of subjects: 25

Group type: COMPARATOR
Intervention: Comparison of product A and product B
Number of subjects: 25
Study: 26581140

Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil/Leucovorin (FL)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Irinotecan/S-1 (IS)
Number of subjects: 142
Study: 23483223

Group type: COMPARATOR
Intervention: H-FABP levels in SCI patients (paraplegia group: 18.5 ± 11.4 ng/ml; tetraplegia group: 16.3 ± 9.1 ng/ml)
Number of subjects: 56

Group type: COMPARATOR
Intervention: H-FABP levels in complete SCI patients with lesions above T6 (24.21 ± 10.1 ng/ml)
Number of subjects: 56

Group type: COMPARATOR
Intervention: H-FABP levels in SCI patients with metabolic syndrome (MetS) (25.8 ± 11.6 ng/ml)
Number of subjects: 56

Group type: COMPARATOR
Intervention: H-FABP levels in SCI patients with duration < 12 months (14.8 ± 11.7 ng/ml)
Number of subjects: 56
Study: 21093467

Group type: EXPERIMENTAL
Intervention: 1 g red pepper (RP)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Preferred RP dose (1.8 ± 0.3 g/meal for spicy food users, 0.3 ± 0.1 g/meal for non-users)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No red pepper (RP)
Number of subjects: 25
Study: 19179979

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (30 mg/kg bolus, 500 mg/h infusion)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 40
Study: 17331263

Group type: EXPERIMENTAL
Intervention: Exercise on Prescription (EoP) - 16-week supervised training intervention and five counselling sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 14968212

Group type: EXPERIMENTAL
Intervention: Saphenofemoral ligation (Group II, n=26)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Long saphenous stripping (Group I, n=10)
Number of subjects: 36
Study: 11334299

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced (CE) SLINKY MR angiography
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MR DSA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SLINKY MR angiography
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CE SLINKY MR angiography
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-CE SLINKY MR angiography
Number of subjects: 40
Study: 9298912

Group type: EXPERIMENTAL
Intervention: Disposable reinforced gowns
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Disposable single layer gowns
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Reusable cloth gowns
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Disposable gowns (general)
Number of subjects: 500
Study: 8390232

Group type: EXPERIMENTAL
Intervention: Estrogen plus progesterone replacement therapy (conjugated estrogen 1.25 mg/d and medroxyprogesterone acetate 10 mg/d for 10 days a month)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Estrogen plus progesterone replacement therapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Washout group (post-treatment follow-up)
Number of subjects: 55
Study: 3731606

Group type: EXPERIMENTAL
Intervention: Cefamandole nafate
Number of subjects: 715

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 715
Study: 31203233

Group type: EXPERIMENTAL
Intervention: APOB, APOC3, and its subfractions (heparin precipitate, heparin‐soluble), ADLS‐defined Lp‐B
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: APOC3 and its subfractions, Lp-B:C
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: APOA1, APOA2, APOE, or other ADLSs
Number of subjects: 465
Study: 30401004

Group type: EXPERIMENTAL
Intervention: Energy restriction (ER) - 25 % (2622 (sd 204) kJ) of estimated energy requirements
Number of subjects: 14

Group type: COMPARATOR
Intervention: Energy balance (EB) - 100 % (10 441 (sd 812) kJ) of estimated energy requirements
Number of subjects: 14
Study: 26590124

Group type: EXPERIMENTAL
Intervention: Jian Pi Li Qi (JPLQ) decoction treatment (group C)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo treatment (group B)
Number of subjects: 150

Group type: COMPARATOR
Intervention: No treatment (group A)
Number of subjects: 150
Study: 25219563

Group type: EXPERIMENTAL
Intervention: ProQuad® (MMRV) first dose
Number of subjects: 3112

Group type: EXPERIMENTAL
Intervention: ProQuad® (MMRV) second dose
Number of subjects: 3112
Study: 22395643

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 1203

Group type: COMPARATOR
Intervention: Anastrozole
Number of subjects: 1203
Study: 21142737

Group type: EXPERIMENTAL
Intervention: Active device (combined light and heat energy)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 16730335

Group type: EXPERIMENTAL
Intervention: Risperidone (8-week treatment)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (8-week treatment)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Risperidone (6-month follow-up)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Risperidone (22-month follow-up)
Number of subjects: 101
Study: 16226614

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg
Number of subjects: 378

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study: 14646453

Group type: EXPERIMENTAL
Intervention: Verbal self-monitoring paradigm (reading single adjectives under various conditions)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Verbal self-monitoring paradigm (reading aloud with acoustic distortion, alien feedback, and distorted alien feedback)
Number of subjects: 20
Study: 11020749

Group type: EXPERIMENTAL
Intervention: Caudal S(+)-ketamine 1 mg/kg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Intramuscular S(+)-ketamine 1 mg/kg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Caudal S(+)-ketamine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Intramuscular S(+)-ketamine
Number of subjects: 42
Study: 8880596

Group type: EXPERIMENTAL
Intervention: Hyperventilation (unmonitored)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitored, cautious, and selective approach to hyperventilation
Number of subjects: 0